AssetMark’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$785 Hold
47
– – ﹤0.01% 3287
2026
Q2
$721 Hold
47
– – ﹤0.01% 3218
2026
Q1
$675 Hold
47
– – ﹤0.01% 3120
2025
Q4
$707 Hold
47
– – ﹤0.01% 3027
2025
Q3
$678 Sell
47
-250
-84% -$3.55K ﹤0.01% 2874
2025
Q2
$4.24K Hold
297
– – ﹤0.01% 2181
2025
Q1
$4.42K Hold
297
– – ﹤0.01% 2020
2024
Q4
$4.28K Hold
297
– – ﹤0.01% 1964
2024
Q3
$4.7K Hold
297
– – ﹤0.01% 1740
2024
Q2
$4.56K Buy
297
+104
+54% +$1.58K ﹤0.01% 1617
2024
Q1
$3.16K Buy
+193
New +$3.04K ﹤0.01% 1526

Other funds holding BMEZ

AssetMark's BMEZ Position: Q3 2026 in Review

AssetMark held its BlackRock Health Sciences Trust II (BMEZ) position steady in Q3 2026 at 47 shares worth $785. The position accounts for ﹤0.01% of the portfolio, ranked #3287.

AssetMark first reported a position in BMEZ in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.7K in Q3 2024. 70 funds tracked by Wall St. Rank hold BMEZ as of Q3 2026.

  • AssetMark held 47 shares of BlackRock Health Sciences Trust II worth $785 as of Q3 2026.
  • AssetMark left its BlackRock Health Sciences Trust II share count unchanged in Q3 2026.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3287 holding.
  • AssetMark first reported a position in BlackRock Health Sciences Trust II in Q1 2024 and has held it in 11 quarters since.
  • AssetMark's BlackRock Health Sciences Trust II position peaked at $4.7K in Q3 2024.
  • 70 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.